Six capabilities, coordinated as one pathway.
The work of moving a therapy from scientific promise to real-world access is not modular. We keep it coherent.
Regulatory & Market Entry
ANVISA, CONITEC, RENAME and access frameworks — navigated with disease-specific evidence packages and realistic timelines.
Clinical & Institutional Partnerships
Activation of hospitals, academic centers and investigator networks with real cohort access.
Patient Identification & Diagnostic Support
Coordination with clinicians and patient communities to shorten diagnostic odysseys — always under medical oversight.
Data & Bioinformatics Intelligence
Phenotypic mapping, cohort stratification and real-world evidence workflows powered by our platform.
Access & Distribution Coordination
Continuity of care design across the last mile: acquisition, logistics, patient support, longitudinal follow-up.
Boston Biotech Business Development
Embedded engagement with the Kendall Square ecosystem to connect programs to Brazilian execution.
How we work with partners
- 01
Discovery
Program, evidence, geography, cohort feasibility.
- 02
Framework
A tailored clinical, regulatory and access plan.
- 03
Activation
Sites, investigators, ethics, agreements.
- 04
Execution
Operations, evidence, patient identification.
- 05
Continuity
Access, distribution, real-world evidence.
Building rare disease infrastructure, together.
If you are advancing a therapy, investing in the space, running a clinical program or coordinating patient identification — start a conversation with us.